Key areas we provide support for biotechs
Explore more about where our deep expertise in Life Sciences can drive success for biotech companies.
Ai-driven R&D
Unlock the potential of AI and machine learning to revolutionize drug discovery, streamline clinical trial design, and predict outcomes with precision. We help you identify and implement the right use cases to accelerate lab-to-launch, transforming how you innovate.
Empowering emerging biotechs
Fuel your biotech's journey to market with breakthrough innovation. We help you scale faster, bringing transformative products to life—no need for big pharma backing.
Patient-centric value chains
Supporting launch and roll-out of advanced medicinal therapies, such as cell & gene, with our solutions.
Collaborative innovation ecosystems
Create powerful, seamless partnerships across CDMOs, CROs, tech leaders, and research institutions. Together, we accelerate discovery and drive breakthrough development.
Regulatory acceleration
Navigate fast-track approvals with expert guidance. We help you adapt to evolving regulations, bringing your innovative therapies to market faster.
Transforming healthcare
Empowering the creation and breakthrough commercialization of cutting-edge gene therapies, cell therapies, and revolutionary advanced medicinal products.
Redefining biotech: The future of advanced therapies
In the rapidly evolving biotech industry, Advanced Medicinal Therapeutic Products (AMTPs) are revolutionizing healthcare, transforming how we treat diseases and improving patient outcomes. Powered by cutting-edge innovations like gene and cell therapies, AMTPs are unlocking limitless possibilities in personalized medicine, creating therapies tailored precisely to individual needs.
Distributed manufacturing: Bringing treatments closer to patients
At the core of this revolution is distributed manufacturing, a game-changing approach that decentralizes production, making it possible to scale therapies faster, more efficiently, and closer to the patient. This bold shift not only accelerates delivery but redefines accessibility, bringing advanced treatments to global populations faster than ever before.
A new era of healthcare innovation
This is the next era of healthcare—one that empowers life-changing breakthroughs and reimagines what’s possible for patients around the globe.
AI and ML: Transforming drug development
The biotech landscape is also being supercharged by AI and machine learning. These technologies are transforming drug development, automating research, optimizing processes, and enabling unprecedented levels of innovation. From identifying new therapeutic targets to enhancing global partnerships, AI and ML are driving smarter collaboration across borders, seamlessly connecting research hubs, manufacturers, and healthcare providers worldwide.
Strategic growth: Navigating the path to success
From initial concept to becoming a commercial powerhouse, biotechs must strategically navigate opportunities while sidestepping costly trends. By balancing the risks of innovation and selecting the right use cases and technologies, they can drive success with a disciplined approach—ensuring sustainable growth and avoiding funding shortfalls before reaching approval. Tenthpin business and technical consultants are your specialized partner all along the way.
The future of biotech: Breaking global barriers
As these forces converge, they are creating a new frontier in biotech, one where global partnerships fueled by technology and innovation are breaking barriers and pushing the boundaries of what’s possible. With limitless potential on the horizon, biotech is ushering in a future where cutting-edge therapies, powered by AI-driven insights, reach patients faster, more affordably, and more effectively than ever before.
Are you looking for support in tackling the challenges in the biotech industry?
Connect with us.
Michael Schmidt
Partner & Member of the Executive Board, Switzerland
INSIGHTS
Related insights
Many Life Sciences companies recognize the need to innovate, but struggle with where and how to begin. That’s not a surprise....
AI is no longer a future ambition in Life Sciences, it is here. Executives are under pressure to move beyond pilots and deliver...
Innovation is critical, but it’s also complex. In the highly regulated, data-intensive world of Life Sciences, success requires...
